Pharmacokinetics and Dose Response after Intravenous and Subcutaneous Administration of Recombinant Erythropoietin in Patients on Regular Haemodialysis Treatment or Continuous Ambulatory Peritoneal Dialysis

Felix Stockenhuber,U. Loibl,M. Gottsauner-Wolf,Christian Jahn,W. Manker,Th.F. Meisl,Balcke P

Pharmacokinetics and Dose Response after Intravenous and Subcutaneous Administration of Recombinant Erythropoietin in Patients on Regular Haemodialysis Treatment or Continuous Ambulatory Peritoneal Dialysis

1991

Felix Stockenhuber
U. Loibl
M. Gottsauner-Wolf
Christian Jahn
W. Manker
Th.F. Meisl
Balcke P

The pharmacokinetics and dose response of recombinant human erythropoietin (rhEPO), administered intravenously and subcutaneously, were studied in chronic haemodialysis (HD) patients and in patients o

Keywords:

Continuous ambulatory peritoneal dialysis
Erythropoietin
Endocrinology
Internal medicine
Anemia
Ambulatory
Urology
Route of administration
Peritoneal dialysis
Hemodialysis
Surgery
Medicine
Pharmacokinetics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations